Ingestible to diagnose GI disorders

Progenity, a San Diego biotech, is “developing the PIL Dx diagnostic capsule to analyze samples from specific locations of the GI tract. Once ingested, the capsule is designed to communicate wirelessly with a wearable RF receiver to report on status and other operational data. We have several ingestible capsule technologies in development, and our most advanced investigational PIL Dx capsule is the Smart Capsule Bacterial Detection System (SCBDS). . . .”  Their technology is promising, but the company’s stock value is plummeting.  MORE

Image Credit:  Wikimedia.commons.org